Support

Story preview

Retatrutide delivers 18.8% average weight loss in Phase III trial of people with type 2 diabetes

diabetes.co.uk

About this story

Published
Oct 15, 2026, 2:25 AM UTC

Topics in this story

#retatrutide#delivers#average#weight#loss

Continue reading on the publisher site for the full article.

Read on publisher →www.diabetes.co.uk

News Atlas is free and independent. If it’s useful to you, you can support it with a coffee. ☕ Buy me a coffee

At a glance

Coverage

Tone

Who else is covering this

Where in the world it’s covered

Coverage over time

Tone of the coverage

About the publisher

Related topics

Retatrutide delivers 18.8% average weight loss in Phase III trial of people with type 2 diabetes · News Atlas